Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
News Briefing channel feed
FDA OKs new label expansions for Dupixent and Incyte's Monjuvi
8 hours ago
Bavarian Nordic's PRV goes for $160M; Biomea to advance GLP-1 into trials
2 days ago
Prothena moves forward with layoffs; Aldeyra resubmits dry eye drug to FDA
3 days ago
Incyte’s promising thrombocythemia drug; Crescent Biopharma raises $200M in PIPE
4 days ago
Rein Therapeutics study on clinical hold; Beam updates sickle cell therapy data
Last week
ADC Therapeutics reveals layoffs, $100M PIPE; Third Harmonic seeks buyer for asset
Last week
Lilly pledges more than $650M to muscle health biotech; Cogent gets $50M
Last week
Insmed’s stock rallies on PAH data; Unicycive aims to resolve CDMO issues
Last week
Avidity to seek accelerated approval for FSHD drug; Axsome to run another trial
Last week
Kelun's $250M PIPE; Valneva moves chikungunya vaccine to Phase 3 for kids
2 weeks ago
Cullinan's deal for T cell engager from China; Kardigan buys late-stage heart drug
3 weeks ago
Vigil drug fails a Phase 2; Merus aims to raise $300M
3 weeks ago
Vera redraws the terms of up to $500M credit facility; Trevi aims to raise $100M
3 weeks ago
Sanofi pays out two STAT6 milestones; Theravance sells more Trelegy royalties
3 weeks ago
Roche’s 96-week data for multiple sclerosis drug; ZymeWorks claims $20M milestone
3 weeks ago
Taysha’s pivotal trial plans; Keros to stop work on PAH drug, lay off 45% of staff
4 weeks ago
Veru’s obesity drug roughly as safe as Wegovy; Keros’ board fight
4 weeks ago
ITM reveals up to $262M debt financing; Caris Life Sciences to go public
4 weeks ago
GLP-1s may cut cancer risk; Gyre’s stock falls after hep B data and offering
4 weeks ago
Moderna pulls application for Covid-flu shot; Another IPO in Hong Kong
5 weeks ago
SV Health’s $269M dementia fund; Schrödinger lays off 7% of staff
Last month
Ionis details late-stage data for heart drug; Armata’s promising staph infection therapy
Last month
FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval
Last month
Enliven stops work on solid tumor drug; Pulmatrix to divest assets
Last month
1
2
3
4
Next page
Last page